#36. Novel therapeutic development with serine biosynthesis inhibition and molecularly targeted drugs against the aggressive osteosarcoma

• Toshinao Oyama,
• Richa Rathore,
• Caitlyn B. Brashears,
• Katharine E. Caldwell,
• Brian A. Van Tine

Affiliations

Toshinao Oyama

Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO 63110, United States

Richa Rathore

Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO 63110, United States

Caitlyn B. Brashears

Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO 63110, United States

Katharine E. Caldwell

Department of Surgery, Division of Hepatobiliary Surgery, Washington University in St. Louis, St. Louis, MO 63110, USA

Brian A. Van Tine

Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO 63110, United States; Siteman Cancer Center, St. Louis, MO 63110, United States; Department of Pediatrics, Washington University in St. Louis, St Louis, MO 63110, United States